Successful treatment of adalimumab in a child with Vogt-Koyanagi-Harada: which is the best available systemic treatment?
Clin Exp Rheumatol
.
2021 Nov-Dec;39(6):1453-1454.
doi: 10.55563/clinexprheumatol/fz25go.
Epub 2021 Jun 8.
Authors
Ilaria Maccora
1
,
Valerio Maniscalco
2
,
Edoardo Marrani
2
,
Cinzia de Libero
3
,
Ilaria Pagnini
2
,
Maria Vincenza Mastrolia
4
,
Gabriele Simonini
4
Affiliations
1
Rheumatology Unit, Meyer Children's University Hospital, Florence, and Neurofarba Department, University of Florence, Italy.
[email protected]
.
2
Rheumatology Unit, Meyer Children's University Hospital, Florence, Italy.
3
Ophthalmology Unit, Meyer Children's University Hospital, Florence, Italy.
4
Rheumatology Unit, Meyer Children's University Hospital, Florence, and Neurofarba Department, University of Florence, Italy.
PMID:
34128787
DOI:
10.55563/clinexprheumatol/fz25go
No abstract available
Publication types
Letter
MeSH terms
Adalimumab* / therapeutic use
Child
Humans
Substances
Adalimumab